Medicine
Somavert kit
Somavert kit is a prescription medicine containing Pegvisomant, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. If not used within 30 days at room temperature, the vial(s)…
Key facts
- Active ingredient (INN)
- Pegvisomant
- Brand
- Somavert
- Dosage form
- Kit
- Packs
- 1 kit, 30 kits and 7 more
- Marketing authorisation holder
- Pharmacia & Upjohn
- Manufacturer
- Pharmacia & Upjohn
- Origin register
- US FDA, United States
- Storage
- Do not freeze. If not used within 30 days at room temperature, the vial(s) should be discarded. The prefilled syringe(s) may be stored at a temperature up to 30°C (86°F) until the expiration date printed on the carton, at which point they should be discarded. Prior to reconstitution: • The One Day Package of SOMAVERT should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01AX01 Pegvisomant
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2016
- Identifiers
- RxCUI 403806, 403807, 403808 +7DailyMed set ID 3cbb485b-6df1-49ce-8747-592b395b1988NDC 0009-7200, 0009-7199, 0009-7166 +2Application BLA021106
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7166-01 | Pharmacia & Upjohn | 1 October 2016 |
| 30 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7166-30 | Pharmacia & Upjohn | 17 January 2022 |
| 1 kit in 1 carton * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7168-01 | Pharmacia & Upjohn | 1 October 2016 |
| 30 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7168-30 | Pharmacia & Upjohn | 17 January 2022 |
| 1 kit in 1 carton * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7188-01 | Pharmacia & Upjohn | 1 October 2016 |
| 30 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7188-30 | Pharmacia & Upjohn | 17 January 2022 |
| 1 kit in 1 carton * 1 mL in 1 syringe * 1 mL in 1 vial, single-dose | 0009-7199-01 | Pharmacia & Upjohn | 1 October 2016 |
| 30 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 syringe * 1 mL in 1 vial, single-dose | 0009-7199-30 | Pharmacia & Upjohn | 17 January 2022 |
| 1 kit in 1 carton * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7200-01 | Pharmacia & Upjohn | 1 October 2016 |
| 30 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 vial, single-dose * 1 mL in 1 syringe | 0009-7200-30 | Pharmacia & Upjohn | 17 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Pegvisomant is a prescription medicine indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. It is available as kits. MedsAcross supplies Pegvisomant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PegvisomantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SOMAVERT prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
- Somavert: European public assessment report (EPAR) · European Medicines Agency
Need Somavert kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.